Gene · 6853
Papers3,694
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,694
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interferon-γ exposure of human iPSC-derived neurons alters major histocompatibility complex I and synapsin protein expression. | Front Psychiatry | 2022 | 36186864 | PubTator, text mining | PubMed |
| Incisionless targeted adeno-associated viral vector delivery to the brain by focused ultrasound-mediated intranasal administration. | EBioMedicine | 2022 | 36152518 | PubTator, text mining | PubMed |
| The Effect of Liquid-Phase Exfoliated Graphene Film on Neurodifferentiation of Stem Cells from Apical Papilla. | Nanomaterials (Basel) | 2022 | 36144905 | PubTator, text mining | PubMed |
| Optical Activation of TrkB (E281A) in Excitatory and Inhibitory Neurons of the Mouse Visual Cortex. | Int J Mol Sci | 2022 | 36142154 | PubTator, text mining | PubMed |
| Neurovascular Unit-Derived Extracellular Vesicles: From Their Physiopathological Roles to Their Clinical Applications in Acute Brain Injuries. | Biomedicines | 2022 | 36140248 | PubTator, text mining | PubMed |
| Clusterin transduces Alzheimer-risk signals to amyloidogenesis. | Signal Transduct Target Ther | 2022 | 36138003 | PubTator, text mining | PubMed |
| Pathological oligodendrocyte precursor cells revealed in human schizophrenic brains and trigger schizophrenia-like behaviors and synaptic defects in genetic animal model. | Mol Psychiatry | 2022 | 36131044 | PubTator, text mining | PubMed |
| Hub genes for early diagnosis and therapy of adamantinomatous craniopharyngioma. | Medicine (Baltimore) | 2022 | 36123899 | PubTator, text mining | PubMed |
| CX3CL1 Derived from Bone Marrow Mesenchymal Stem Cells Inhibits Aβ 1-42-Induced SH-SY5Y Cell Pathological Damage through TXNIP/NLRP3 Signaling Pathway. | Comput Math Methods Med | 2022 | 36118839 | PubTator, text mining | PubMed |
| The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review. | Front Neurosci | 2022 | 36117625 | PubTator, text mining | PubMed |
| Distinct neurotoxic TDP-43 fibril polymorphs are generated by heterotypic interactions with α-Synuclein. | J Biol Chem | 2022 | 36116552 | PubTator, text mining | PubMed |
| Xeno-free induced pluripotent stem cell-derived neural progenitor cells for in vivo applications. | J Transl Med | 2022 | 36114512 | PubTator, text mining | PubMed |
| Structures of α-synuclein filaments from human brains with Lewy pathology. | Nature | 2022 | 36108674 | PubTator, text mining | PubMed |
| The potential of plant extracts in cell therapy. | Stem Cell Res Ther | 2022 | 36104798 | PubTator, text mining | PubMed |
| Fluorochromized tyramide-glucose oxidase as a multiplex fluorescent tyramide signal amplification system for histochemical analysis. | Sci Rep | 2022 | 36097273 | PubTator, text mining | PubMed |
| Crosstalk of Synapsin1 palmitoylation and phosphorylation controls the dynamicity of synaptic vesicles in neurons. | Cell Death Dis | 2022 | 36097267 | PubTator, text mining | PubMed |
| Lead exposure represses mitochondrial metabolism by activation of heme-binding protein BACH1 in differentiated SH-SY5Y cell. | Sci Total Environ | 2022 | 36096218 | PubTator, text mining | PubMed |
| A zona incerta-basomedial amygdala circuit modulates aversive expectation in emotional stress-induced aversive learning deficits. | Front Cell Neurosci | 2022 | 36090791 | PubTator, text mining | PubMed |
| Protective Effects of Pioglitazone on Cognitive Impairment and the Underlying Mechanisms: A Review of Literature. | Drug Des Devel Ther | 2022 | 36068789 | PubTator, text mining | PubMed |
| Multidimensional Early Prediction Score for Drug-Resistant Epilepsy. | J Clin Neurol | 2022 | 36062773 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6853/papers?page=34